產(chǎn)品中心Products Resources
聯(lián)系我們CONTACT US
-
400 179 0116
24小時(shí)服務(wù)熱線
當(dāng)前位置：首頁 > 產(chǎn)品中心(Products) > 定制細(xì)胞(Customized Cells) > 腫瘤細(xì)胞(Tumor Cell Lines) > 人源腫瘤細(xì)胞(human Tumor cells) > CERV-196
產(chǎn)品描述/Products Description
The CERV-196 cell line was established from a poorly differentiated squamous cell carcinoma of the cervix; HPV-16 positive. In vitro established from the xenotransplant cervix carcinoma MRI-H-196 by Cell Lines Service. Primary xenotransplant was adopted to in vivo transplantation by Dr. Bodgen, Mason Research Institute.
